Interleukin-13: Characterization and biologic properties

  • Andrew N. J. McKenzie
  • Gerard Zurawski
Part of the Cancer Treatment and Research book series (CTAR, volume 80)


Upon activation by antigen, helper T cells respond by secreting factors, called cytokines, that coordinate the immune response. The type of T-cell response initiated depends upon the antigenic stimulus and can result in a polarization of the spectrum of cytokines secreted. A subset of helper T cells, referred to as TH1 cells, secrete principally interleukin-2 (IL-2) and interferon- γ (IFN-γ) and induce delayed-type hypersensitivity reactions. Another T-cell subset, termed TH2, is characterized by the production of IL-4 and IL-5 and primarily appears to regulate antibody responses [1]. The past few years have seen this ‘cytokine network’ increasing in complexity with the unremitting discovery of additional immunoregulatory proteins. The most recent additions to the cytokine network have been factors such as IL-13 and IL-15 which share many, but not all, of their biological activities with cytokines described previously, namely IL-4 and IL-2, respectively [2–4]. This coincidence of function is paralleled by these cytokines sharing at least some of their receptor components [5–7], and it is now clear that this mechanism is repetitively utilized in the immune system [8]. A full understanding of the immune system will require knowledge of the role each newly described cytokine plays in immune responses. This review will discuss our current understanding of how IL-13 is utilized in immune reactions.


Human Polymorphonuclear Cell Cytokine Gene Cluster Regulate Antibody Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173, 1989.PubMedCrossRefGoogle Scholar
  2. 2.
    McKenzie ANJ, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, deVries JE, Banchereau J, Zurawski G. Interleukin-13, a novel T cell-derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci USA 90:3735–3739, 1993.PubMedCrossRefGoogle Scholar
  3. 3.
    Minty A, Chalon P, Derocq J-M, Dumont X, Guillemot J-C, Kaghad K, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D. Interleukin-13: A novel human lymphokine regulating inflammatory and immune responses. Nature 362:248–250, 1993.PubMedCrossRefGoogle Scholar
  4. 4.
    Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965–968, 1994.PubMedCrossRefGoogle Scholar
  5. 5.
    Zurawski SM, Vega F Jr, Huyghe B, Zurawski G. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12:3899–3905, 1993.Google Scholar
  6. 6.
    Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874–1877, 1993.PubMedCrossRefGoogle Scholar
  7. 7.
    Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann FC, Miyajima A, Puri RK, Paul WE, Leonard WJ. Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262:1880–1883, 1993.PubMedCrossRefGoogle Scholar
  8. 8.
    Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: A paradigm for cytokines. Science 258:593–597, 1992.PubMedCrossRefGoogle Scholar
  9. 9.
    Brown KD, Zurawski SM, Mosmann TR, Zurawski G. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocytes and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol 142:679–687, 1989.PubMedGoogle Scholar
  10. 10.
    Morgan JG, Dolganov GM, Robbins SE, Hinton LM, Lovett M. The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes. Nucleic Acids Res 20:5173–5179, 1992.PubMedCrossRefGoogle Scholar
  11. 11.
    Lakkis FG, Cruet EN. Cloning of rat interleukin-13 (IL-13) cDNA and analysis of IL-13 gene expression in experimental glomerulonephritis. Biochem Biophys Res Commun 197:612–618, 1993.PubMedCrossRefGoogle Scholar
  12. 12.
    McKenzie ANJ, Li X, Largaespada DA, Sato A, Kaneda A, Zurawski SM, Doyle EL, Francke U, Copeland NG, Jenkins NA, Zurawski G. Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 150:5436–5444, 1993.PubMedGoogle Scholar
  13. 13.
    Chandrasekharappa SC, Rebelsky MS, Firak TA, Le Beau MM, Westbrook CA. A long-range restriction map of the interleukin-4 and interleukin-5 linkage group on chromosome 5. Genomics 6:94–99, 1990.PubMedCrossRefGoogle Scholar
  14. 14.
    Lee JS, Campbell HD, Kozak CA, Young IG. The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome 11. Somat Cell Mol Genet 15:143–152, 1989.PubMedCrossRefGoogle Scholar
  15. 15.
    Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD. Interleukin-4 and interleukin-5 map to chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q). Blood 73:647–650, 1989.PubMedGoogle Scholar
  16. 16.
    Bazan JF. Haemopoietic receptors and helical cytokines. Immunol Today 11:350, 1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Walter MR, Cook WJ, Zhoa BG, Cameron RP Jr, Ealick SE, Walter RL Jr, Reichert P, Nagabhushan TL, Trotta PP, Bugg CE. Crystal structure of recombinant human interleukin-4. J Biol Chem 267:20371–20376, 1992.PubMedGoogle Scholar
  18. 18.
    Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 166:1229–1244, 1987.PubMedCrossRefGoogle Scholar
  19. 19.
    Reiner SL, Zheng S, Wang Z-E, Stowring L, Locksley RM. Leishmania promastigotes evade interleukin-12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med 179:447–456, 1994.PubMedCrossRefGoogle Scholar
  20. 20.
    Wang Z-E, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon-γ-deficient mice infected with Leishmania major. J Exp Med 179:1367–1371, 1994.PubMedCrossRefGoogle Scholar
  21. 21.
    Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A. Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179: 1551–1561, 1994.PubMedCrossRefGoogle Scholar
  22. 22.
    Zurawski G, deVries JE. 1991. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today, 15:19–26.CrossRefGoogle Scholar
  23. 23.
    Jacobsen SEW, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A. Interleukin-13: Novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells. J Exp Med 180:75–82, 1994.PubMedCrossRefGoogle Scholar
  24. 24.
    te Velde AA, Klomp JPG, Yard BA, deVries JE, Figdor CG. Modulation of phenotypic and functional properties of human peripheral blood monocytes. J Immunol 140:1548–1554.Google Scholar
  25. 25.
    Vercelli D, Jabara HH, Lee B-L, Woodland N, Geha RS, Leung DYM. Human recombinant interleukin-4 induces FcER/CD23 on normal human monocytes. J Exp Med 167: 1406–1416, 1988.PubMedCrossRefGoogle Scholar
  26. 26.
    de Waal Malefyt R, Figdor C, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, deVries JE. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 151:6370–6381, 1993.PubMedGoogle Scholar
  27. 27.
    Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A, Colotta F. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-lra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-Ira in human myelomonocytic cells. Blood 83:1738–1743, 1994.PubMedGoogle Scholar
  28. 28.
    Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem 269:12403–12406, 1994.PubMedGoogle Scholar
  29. 29.
    Hsieh C-S, Macatonia SE, Tripp CA, Wolf SF, O’Garra A, Murphy KM. Development of Th1 CD4+ T cells through IL-12 produced by listeria-induced macrophages. Science 260: 547–549, 1993.PubMedCrossRefGoogle Scholar
  30. 30.
    Herbert JM, Savi P, Laplace M-Cl, Lale A, Dol F, Dumas A, Labit C, Minty A. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Letters 328:268–270, 1993.PubMedCrossRefGoogle Scholar
  31. 31.
    Derocq J-M, Segui M, Poinot-Chazel C, Minty A, Caput D, Ferrara P, Casellas P. Interleukin-13 stimulates interleukin-6 production by kerationcytes: Similarity with interleukin-4. FEBS Letters 343:32–36, 1994.Google Scholar
  32. 32.
    Montaner LJ, Doyle AG, Collin M, Herbein G, Illei P, James W, Minty A, Caput D, Ferrar P, Gordon S. Interleukin-13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med 178:743–747, 1993.PubMedCrossRefGoogle Scholar
  33. 33.
    Doherty TM, Kastelein R, Menon S, Andrade S, Coffman RL. Modulation of murine macrophage function by interleukin-13. J Immunol 151:7151–7160, 1993.PubMedGoogle Scholar
  34. 34.
    Doyle AG, Herbein G, Montaner LJ, Minty A, Caput D, Ferrara P, Gordon S. Interleukin-13 alters the activation state of murine macrophages in vitro: Comprison with interleukin-4 and interferon-γ. Eur J Immunol 24:1441–1445, 1994.PubMedCrossRefGoogle Scholar
  35. 35.
    Defrance T, Carayon P, Billian G, Guillemot J-C, Minty A, Caput D, Ferrara P. Interleukin-13 is a B cell stimulating factor. J Exp Med 179:135–143, 1994.PubMedCrossRefGoogle Scholar
  36. 36.
    Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, deVries JE. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD33 expression by B cells. Proc Natl Acad Sci USA 90:3730–3735, 1993.PubMedCrossRefGoogle Scholar
  37. 37.
    Cocks BG, de Waal Malefyt R, Galizzi J-P, deVries JE, Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol 5:657–663, 1993.PubMedCrossRefGoogle Scholar
  38. 38.
    Kuhn R, Rajewski K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 254:707–710, 1991.PubMedCrossRefGoogle Scholar
  39. 39.
    Hsu D-H, Moore KW, Spits H. Differential effects of IL-4 and IL-10 on IL-2-induced IFNγ synthesis and lymphokine-activated killer activity. Int Immunol. 4:563–569, 1991.CrossRefGoogle Scholar
  40. 40.
    Kruse N, Tony HP, Sebald W. Conversion of human interleukin-4 into high affinity antagonist by single amino acid replacement. EMBO J 11:3237–3244, 1992.PubMedGoogle Scholar
  41. 41.
    Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa S-I, Sugamura K. Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453–1454, 1994.PubMedCrossRefGoogle Scholar
  42. 42.
    Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262:1877–1880, 1993.PubMedCrossRefGoogle Scholar
  43. 43.
    Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F Jr, Zurawski SM, Zurawski G, deVries JE. An interleukin-4 (IL-4) mutant protein inhibits both IL-4 and IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178:2213–2218, 1993.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Andrew N. J. McKenzie
  • Gerard Zurawski

There are no affiliations available

Personalised recommendations